Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Journal:
Current Genomics
Volume:
10
Page:
281-293
Author(s):
E. Kirches
HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
451-468
Author(s):
Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi
The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
566-571
Author(s):
Yonghui Yu, Yu Wan and Chuanshu Huang
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
572-594
Author(s):
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu
HER2 Targeted Therapies for Cancer and the Gastrointestinal Tract
Journal:
Current Drug Targets
Volume:
10
Page:
537-542
Author(s):
Noor Al-Dasooqi, Rachel Gibson, Joanne Bowen and Dorothy Keefe
STAT3 as a Central Regulator of Tumor Metastases
Journal:
Current Molecular Medicine
Volume:
9
Page:
626-633
Author(s):
Eswaran Devarajan and Suyun Huang
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Journal:
Current Gene Therapy
Volume:
9
Page:
160-170
Author(s):
Sander W. Tas, Margriet J.B.M. Vervoordeldonk and Paul P. Tak
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
151-177
Author(s):
S. Rutella, G. Bonanno and R. De Cristofaro
Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
110-124
Author(s):
Yu-Wen E. Chang, Ronald R. Bean and Rolf Jakobi
Paving Roads for New Drugs in Oncology
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
137-145
Author(s):
Kurt S. Zaenker and Frank Entschladen